Transanal Endoscopic-Assisted Pull-Through Colectomy for Children with High Intestinal Aganglionosis

Ulrike Metzger1, Armin-Johannes Michel1, Mircia-Aurel Ardelean1

  • 1Department of Pediatric and Adolescent Surgery, Paracelsus Medical University Hospital, 5020 Salzburg, Austria.

Insights

This study introduces a modified transanal pull-through colectomy for treating intestinal aganglionosis in children. This technique minimizes surgical trauma by using only an umbilical camera, avoiding additional trocars for improved outcomes.

Area of Science:

  • Pediatric Surgery
  • Gastrointestinal Surgery
  • Surgical Innovation

Background:

  • Intestinal aganglionosis, a leading cause of neonatal and infantile intestinal obstruction, requires surgical intervention.
  • The standard therapeutic approach involves resection of the affected bowel segment and endorectal pull-through (ERP).
  • Traditional ERP may necessitate laparoscopic or laparotomy assistance for complex cases or high aganglionosis.

Observation:

  • Two cases are presented detailing a technical modification for a totally transanal pull-through colectomy.
  • This novel technique utilizes only an umbilical camera trocar, foregoing additional laparoscopic or abdominal trocars.
  • Preparation is advanced transanally, with laparoscopic visualization via the umbilical camera to complete dissection directly through the anus.

Findings:

  • The modified procedure allows for complete transanal dissection and pull-through, even in cases typically requiring laparoscopic assistance.
  • Instruments are manipulated directly via the anus under laparoscopic vision, enhancing maneuverability.
  • This approach potentially reduces trauma to the distal anal channel by eliminating the need for transanal trocars.

Implications:

  • This modification combines the benefits of laparoscopic visualization with the minimally invasive advantages of endorectal pull-through.
  • The technique offers excellent visualization while preserving the benefits of sparing dissection inherent to ERP.
  • It represents a promising advancement for treating pediatric intestinal aganglionosis, potentially leading to reduced patient morbidity.